AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Clinical Evaluation of 3-D Printed Partial Denture Space Maintainer

RecruitingNAAges 7 Years - 9 YearsAllTanta University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Primary dentition is the most suitable space maintainer for permanent teeth. However, as infants often lose their primary teeth too soon, using a space maintainer is the most efficient, long-lasting, and economical way to prevent malocclusions and function impairment in the future. Regarding personalized appliances, space maintainers in digital pediatric dentistry have made significant progress. Digital technology decreases the manual manufacturing stages that take a long time and increases the reliability and durability of digital fabrication procedures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * apparently, healthy cooperative children having recent premature loss of lower primary molars * the permanent successors of the lost primary molars were not expected to erupt within 6 months * Angle's class 1 occlusion with normal primary molar relation * Presence of teeth on the mesial and distal side of the edentulous area * Absence of para-functional habits or abnormal occlusion conditions such as crossbite, open bite, or deep bite. * Radiographically, presence of permanent successors. * parents and children were accepting the new treatment modality. Exclusion Criteria: * children exhibited poor oral hygiene, para-functional oral habits, severe crowding, space loss, and abnormal occlusion * Extraction of primary molars exceeding three months. * Radiographically, absence of permanent successor. * uncooperative children
๐Ÿ’Š

What it tests

  • space maintainer
  • space maintainer
๐Ÿ“

Where

2 sites
pediatric dentistry department, faculty of dentistry, Tanta university
Tanta, Egypt
Tanta University
Tanta, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy